Intense tan / stimulates melanin production and erotic effect
Melanotan II is a synthetic cyclic peptide analog of alpha-melanocyte-stimulating hormone (α-MSH), developed to act as a non-selective melanocortin receptor agonist. It exhibits high affinity primarily for MC1R, MC3R, MC4R, and MC5R receptors, being associated with the modulation of melanogenesis and related neuroendocrine pathways.
R$ 690,00
10 in stock
💡 Digite seu CEP para calcular automaticamente o frete e prazo de entrega
We accept USDT as our exclusive payment method, ensuring fast transactions, enhanced privacy, and efficient order processing.
Warning — For Research Use Only
Scientific content intended for research laboratories only. It is not a clinical, therapeutic, or diagnostic recommendation. Use is restricted to qualified professionals. Consult specialists before purchasing or using. Biopelabs reinforces its commitment to ethical and responsible use.
Discover Our Complete Catalog
Browse our full peptide catalog and explore additional compounds. Click any product to view its details and discover more research solutions.
Melanotan II is a synthetic cyclic heptapeptide structurally derived from α-MSH, containing modifications that increase its metabolic stability and resistance to enzymatic degradation. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂, where Nle corresponds to norleucine and D-Phe represents D-configuration phenylalanine, contributing to higher affinity and biological potency.
Cyclization occurs through an intramolecular lactam bond between aspartic acid and lysine residues, conferring greater conformational rigidity. The compound acts as an agonist of G protein-coupled melanocortin receptors, promoting increased melanin production through MC1R activation in melanocytes. It also exhibits activity on central receptors, especially MC4R, associated with appetite regulation and neuroendocrine function.
Due to its synthetic nature and pharmacological potency, Melanotan II is not approved as a medication in many jurisdictions, and its use is predominantly restricted to experimental or research contexts.
Important Information
Properties
Value
Molecular Formula
C₅₀H₆₉N₁₅O₉
Molecular Weight
1024.18 g/mol
Synonyms
MT-II, Melanotan 2, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂, Cyclo(Asp-His-D-Phe-Arg-Trp-Lys) with N-acetyl-norleucine, Cyclic α-MSH analog
Melanotan II Peptide Core Structure
Source: alamy
Lyophilized Peptides
The peptides undergo a lyophilization process, a technique that enhances stability and shelf life while preserving purity and molecular structure throughout storage. It is important to note that no fillers are used during this procedure.
Intended Use
Biopelabs states: this material is provided exclusively as a chemical input for research purposes. Its use is restricted to in vitro assays and experimental activities in laboratory settings. The information presented is strictly for informational and educational purposes. Handling must be carried out only by properly qualified professionals. This product is not classified as a drug, food, or cosmetic and must not be used, marketed, or described as such.
Research
Scientific Research on the Melanotan II Peptide
Melanotan II is a synthetic peptide widely studied in research contexts due to its action on the melanocortin system. Scientific investigations have identified several relevant biological effects, described below.
Stimulation of Melanogenesis
Melanotan II acts as a non-selective agonist of melanocortin receptors (MC1R, MC3R, MC4R, and MC5R), stimulating melanin production by melanocytic cells. This mechanism results in increased skin pigmentation, making it a compound of interest in studies related to melanogenesis biology and cutaneous photoprotection (CellPeptides, 2025; Herbenbio, 2025).
Effects on the Central Nervous System and Sexual Behavior
Research indicates that Melanotan II crosses the blood-brain barrier and activates melanocortin receptors in the central nervous system, especially MC4R. This activation is associated with behavioral changes, including increased sexual arousal and modulation of libido, making the peptide relevant for neuroendocrine and sexual behavior studies. In early clinical studies, 80% of men treated with Melanotan II developed "clinically apparent" spontaneous erections lasting an average of 38 minutes (CellPeptides, 2025).
Applications in Metabolic and Regulatory Research
In addition to effects on pigmentation and sexual behavior, Melanotan II is used in studies investigating appetite regulation, energy balance, and hypothalamic signaling. Its action on multiple melanocortin receptors provides important data for understanding complex biological pathways involved in metabolism and energy homeostasis. Animal studies have shown that Melanotan II reduces food intake and improves insulin sensitivity, with healthier blood glucose levels (CellPeptides, 2025).
Experimental Tool in Melanocortin Receptor Studies
Due to its broad pharmacological profile, Melanotan II is considered a valuable experimental tool in research involving melanocortin receptors. It is used to explore cellular signaling mechanisms, receptor-ligand interactions, and physiological responses associated with these systems.
Anti-inflammatory Potential
Some studies suggest that melanocortin agonists, including Melanotan II, may act as anti-inflammatory agents. This could position the peptide for research into arthritis and other chronic inflammatory conditions (CellPeptides, 2025).
Future Research Directions
Emerging research areas for Melanotan II include its potential role in mood and mental health, given that MC4R receptors play roles in stress, anxiety, and depression expression. Additionally, its possible applications in addiction recovery medicine remain to be explored (CellPeptides, 2025).
Pharmacokinetic Considerations in Research
Administration Route: Nearly all preclinical and clinical studies have used subcutaneous (SC) injections as the administration method. The peptide is reconstituted with bacteriostatic water and injected into adipose tissue just below the skin (CellPeptides, 2025).
Bioavailability and Onset: SC administration provides the peptide with easy systemic entry, allowing researchers to observe its effects from melanocytes in the skin to the hypothalamus, where its sexual effects are activated.
Dosage Protocols: Dosage escalation strategies are commonly employed. One major study began with 0.10 mg, increasing in steps to 0.16 mg, 0.30 mg, 0.50 mg, and finally a maintenance dose of 1.0 mg. Administration frequency varies from daily to every other day (CellPeptides, 2025).
Alternative Delivery Methods: While some research has investigated nasal spray administration (as with the successor peptide Bremelanotide), subcutaneous delivery remains the most common method for Melanotan II.
Other Important Research Relationships
Relationship with Bremelanotide (PT-141): The discovery of Melanotan II's pro-sexual effects directly led to the development of Bremelanotide (PT-141), a derivative peptide now FDA-approved to treat hypoactive sexual desire disorder (HSDD) in women. Unlike Melanotan II, PT-141 targets sexual function without tanning effects (CellPeptides, 2025).
Relationship with Melanotan I: While both are α-MSH analogs with extended half-lives, Melanotan I is more selective, inducing tanning without additional effects. Melanotan II targets more melanocortin receptors, resulting in additional effects on fat burning, appetite control, and libido (CellPeptides, 2025).
Final Considerations
Scientific research on Melanotan II has contributed significantly to advancing knowledge about the melanocortin system. The peptide creates a deep, long-lasting, sunless tan; reduces appetite; improves insulin sensitivity; and enhances sexual function. Its broad receptor activity makes it a fascinating research tool with potential applications ranging from photoprotection and metabolic disorders to sexual dysfunction and inflammatory conditions. However, its use remains restricted to experimental and research contexts, and any investigation must follow rigorous scientific and ethical protocols. Long-term safety data are lacking, and unregulated use poses significant risks, including hyperpigmentation, nevus formation, and potential melanoma risk due to uncontrolled melanin production (Herbenbio, 2025).
Disclaimer: The products offered by BiopeLabs are intended for research and laboratory use only. They are not approved for human consumption, therapeutic, diagnostic, or veterinary use. By purchasing from our website, you acknowledge that you are a qualified researcher or purchasing on behalf of a legitimate research institution and agree to use these products in accordance with all applicable laws and regulations.
Reviews
There are no reviews yet.